| Dr Jeffrey Malden Jones, MD | |
|
5738 Richmond Dr, Fitchburg, WI 53719-1606 | |
| (608) 271-0298 | |
| Not Available |
| Full Name | Dr Jeffrey Malden Jones |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Infectious Disease |
| Location | 5738 Richmond Dr, Fitchburg, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740420173 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 19627 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jeffrey Malden Jones, MD 5738 Richmond Dr, Fitchburg, WI 53719-1606 Ph: (608) 271-0298 | Dr Jeffrey Malden Jones, MD 5738 Richmond Dr, Fitchburg, WI 53719-1606 Ph: (608) 271-0298 |
News Archive
The more information you have, the better able you are to predict what will happen next. Clinicians and health researchers often look at gene mutation to predict whether a fetus is at risk for a birth defect, or a person is at risk of developing a disease, but these predictions are not always accurate.
The Human Fertilisation & Embryology Authority has decided to extend the rules allowing embryos to be tested in order for families to have a child who could be a tissue match for a seriously ill brother or sister.
The application of general anesthesia in clinical therapy has been an indispensable part of modern medicine for more than a century. However, due to the complexity of the brain and the extensive actions of general anesthetic drugs, neural mechanisms underlying general anesthesia have remained a mystery.
ABIVAX an innovative biotechnology company targeting the immune system to eliminate viral disease, announced today that the Company presented new preclinical data on ABX464, ABIVAX's first-in-class drug candidate for a functional cure of patients with HIV/AIDS, during this week's HIV DART scientific conference in Los Cabos, Mexico.
Salix Pharmaceuticals, Ltd. today announced plans for the Hepatic Encephalopathy Living Program (H.E.L.P.). H.E.L.P. is a first-of-its-kind patient and health care provider support program for the management of hepatic encephalopathy (HE) and will launch on May 24, 2010. The program will provide patients with HE educational materials, co-pay assistance, treatment adherence support and a 24-hour toll-free hotline.
› Verified 9 days ago
Dr. Sarah E Panzer, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3034 Fish Hatchery Rd, Fitchburg, WI 53713 Phone: 608-270-5600 | |
Jacalyn A Nelson, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2844 Index Rd, Fitchburg, WI 53713 Phone: 608-229-7979 Fax: 608-229-8110 | |
Rachael Ziska, D.O. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3051 Cahill Main, Fitchburg, WI 53711 Phone: 608-661-7200 | |
Laura Maursetter, D.O. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3034 Fish Hatchery Rd, Fitchburg, WI 53713 Phone: 608-270-5656 | |
Dr. Daniel Joel Mcculley, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 5543 E Cheryl Pkwy, Fitchburg, WI 53711 Phone: 608-263-7740 Fax: 608-262-6048 | |
Dr. Don A Harden, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 2844 Index Rd, Fitchburg, WI 53713 Phone: 608-229-7979 Fax: 608-229-8110 | |
Uzoamaka E Achufusi, MBBS Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3034 Fish Hatchery Rd, Fitchburg, WI 53713 Phone: 608-270-5656 |